LLY
Lilly (Eli) · Health Care
8.2%
typical move (median |reaction| of last 8)
2026-10-29 pre · likely
next expected · estimated from pattern
13
scored events
Last eight reactions
2025-01-14 → 2026-08-05
| date | session | reaction | |move| | excess 5s | excess 20s |
|---|---|---|---|---|---|
| 2026-08-05 | pre | +4.6% | 4.6% | +4.0% | -0.1% |
| 2026-04-30 | pre | +9.8% | 9.8% | +2.5% | +13.1% |
| 2026-02-04 | pre | +10.5% | 10.5% | -9.2% | -10.5% |
| 2025-10-30 | pre | +4.0% | 4.0% | +12.4% | +27.0% |
| 2025-08-07 | pre | -14.2% | 14.2% | +4.9% | +11.4% |
| 2025-05-01 | pre | -11.6% | 11.6% | -6.5% | -12.4% |
| 2025-02-06 | pre | +3.3% | 3.3% | -0.3% | +5.1% |
| 2025-01-14 | pre | -6.6% | 6.6% | -3.0% | +13.6% |
Source filings
2026-08-05 · 8-K press release
August 5, 2026 For release: Immediately Refer to: Megan MacCauley; maccauley_megan@lilly.com (Media) Mike Czapar; czapar_michael_c@lilly.com (Investors) Lilly reports second-quarter 2026 financial res
2026-04-30 · 8-K press release
April 30, 2026 For release: Immediately Refer to: Ashley Hennessey; gentry_ashley_jo@lilly.com; (317) 416-4363 (Media) Mike Czapar; czapar_michael_c@lilly.com; (317) 617-0983 (Investors) Lilly reports
2026-02-04 · 8-K press release
February 4, 2026 For release: Immediately Refer to: Ashley Hennessey; gentry_ashley_jo@lilly.com; (317) 416-4363 (Media) Mike Czapar; czapar_michael_c@lilly.com; (317) 617-0983 (Investors) Lilly repor
2025-10-30 · 8-K press release
October 30, 2025 For release: Immediately Refer to: Ashley Hennessey; gentry_ashley_jo@lilly.com; (317) 416-4363 (Media) Mike Czapar; czapar_michael_c@lilly.com; (317) 617-0983 (Investors) Lilly repor
2025-08-07 · 8-K press release
August 7, 2025 For release: Immediately Refer to: Ashley Hennessey; gentry_ashley_jo@lilly.com; (317) 416-4363 (Media) Mike Czapar; czapar_michael_c@lilly.com; (317) 617-0983 (Investors) Lilly reports
2025-05-01 · 8-K press release
May 1, 2025 For release: Immediately Refer to: Ashley Hennessey; gentry_ashley_jo@lilly.com; (317) 416-4363 (Media) Mike Czapar; czapar_michael_c@lilly.com; (317) 617-0983 (Investors) Lilly reports fi
2025-02-06 · 8-K press release
Feb. 6, 2025 For release: Immediately Refer to: Ashley Hennessey; gentry_ashley_jo@lilly.com; (317) 416-4363 (Media) Mike Czapar; czapar_michael_c@lilly.com; (317) 617-0983 (Investors) Lilly reports f
2025-01-14 · 8-K press release
January 14, 2025 For Release: Immediately Refer to: Carrie Munk; munk_carrie@lilly.com ; 317-416-2393 (Media) Michael Czapar; czapar_michael_c@lilly.com ; 317-617-0983 (Investors) Lilly provides updat